Inventor · disambiguated record
Kirsten Timms
Also filed as: TIMMS KIRSTEN
15 granted patents·23 pending applications·40 citations·filing 2006–2025
90Inventor score
Top patents by PatentIndex Score
38 records- 0195US12221656B2Methods and materials for assessing homologous recombination deficiencyMYRIAD GENETICS INC·Filed 2022·Granted Feb 11, 2025·3 cites·18 claims
- 0293US9574229B2Methods and materials for assessing allelic imbalanceMYRIAD GENETICS INC·Filed 2016·Granted Feb 21, 2017·11 cites·41 claims
- 0393US9279156B2Methods and materials for assessing allelic imbalanceMYRIAD GENETICS INC·Filed 2013·Granted Mar 8, 2016·16 cites·18 claims
- 0487US10626449B2Methods and materials for assessing allelic imbalanceMYRIAD GENETICS INC·Filed 2017·Granted Apr 21, 2020·2 cites·13 claims
- 0586US10612098B2Methods and materials for assessing loss of heterozygosityMYRIAD GENETICS INC·Filed 2016·Granted Apr 7, 2020·2 cites·15 claims
- 0683US11225685B2Methods and materials for assessing allelic imbalanceMYRIAD GENETICS INC·Filed 2020·Granted Jan 18, 2022·1 cites·20 claims
- 0781US2023111438A1Methods and materials for assessing loss of heterozygosityMYRIAD GENETICS INC·Filed 2022·Application pending·0 cites
- 0880US9388472B2Methods and materials for assessing loss of heterozygosityMYRIAD GENETICS INC·Filed 2014·Granted Jul 12, 2016·3 cites·36 claims
- 0980US2025250643A1Methods and materials for assessing loss of heterozygosityMYRIAD GENETICS INC·Filed 2025·Application pending·0 cites
- 1078US11174519B2Method of treating cancerMYRIAD GENETICS INC·Filed 2019·Granted Nov 16, 2021·0 cites·11 claims
- 1178US2022205046A1Methods and materials for assessing loss of heterozygosityMYRIAD GENETICS INC·Filed 2021·Application pending·0 cites
- 1277US2025215509A1Methods and materials for assessing loss of heterozygosityMYRIAD GENETICS INC·Filed 2025·Application pending·0 cites
- 1376US10851425B2Method for treating cancerMYRIAD GENETICS INC·Filed 2019·Granted Dec 1, 2020·0 cites·13 claims
- 1476US2025223655A1Methods and materials for assessing homologous recombination deficiencyMYRIAD GENETICS INC·Filed 2025·Application pending·0 cites
- 1576US2022205022A1Methods and materials for assessing allelic imbalanceMYRIAD GENETICS INC·Filed 2021·Application pending·0 cites
- 1676US2021310079A1Methods and materials for assessing homologous recombination deficiencyMYRIAD GENETICS INC·Filed 2021·Application pending·0 cites
- 1775US2020399713A1Methods and materials for assessing loss of heterozygosityMYRIAD GENETICS INC·Filed 2020·Application pending·0 cites
- 1874US10400287B2Methods and materials for assessing homologous recombination deficiencyMYRIAD GENETICS INC·Filed 2017·Granted Sep 3, 2019·1 cites·6 claims
- 1973US2025179587A1Methods and materials for assessing homologous recombination deficiencyMYRIAD GENETICS INC·Filed 2025·Application pending·0 cites
- 2072US12421555B2Methods and materials for assessing homologous recombination deficiencyMYRIAD GENETICS INC·Filed 2018·Granted Sep 23, 2025·0 cites·10 claims
- 2171US7662566B2Gene copy number profilingMYRIAD GENETICS INC·Filed 2007·Granted Feb 16, 2010·1 cites·7 claims
- 2265US2015080260A1Methods and materials for assessing loss of heterozygosityMYRIAD GENETICS INC·Filed 2014·Application pending·0 cites
- 2364US12410478B2Hereditary cancer genesMYRIAD GENETICS INC·Filed 2021·Granted Sep 9, 2025·0 cites·9 claims
- 2463US2023212653A1Methods and materials for assessing homologous recombination deficiency in breast cancer subtypesMYRIAD GENETICS INC·Filed 2022·Application pending·0 cites
- 2560US2014363521A1Methods and materials for assessing homologous recombination deficiencyMYRIAD GENETICS INC·Filed 2014·Application pending·0 cites
- 2657US2018030544A1Methods and materials for assessing homologous recombination deficiencyMYRIAD GENETICS INC·Filed 2017·Application pending·0 cites
- 2756US2012015050A1Methods and materials for assessing loss of heterozygosityABKEVICH VICTOR·Filed 2011·Application pending·0 cites
- 2855US11104956B2Hereditary cancer genesMYRIAD GENETICS INC·Filed 2014·Granted Aug 31, 2021·0 cites·8 claims
- 2954US7794933B1Depression-related geneMYRIAD GENETICS INC·Filed 2006·Granted Sep 14, 2010·0 cites·1 claims
- 3052US2021262016A1Methods and systems for somatic mutations and uses thereofMYRIAD GENETICS INC·Filed 2021·Application pending·0 cites
- 3149US2015167100A1Hereditary Cancer GenesMYRIAD GENETICS INC·Filed 2014·Application pending·0 cites
- 3248US2007082347A1Gene variants and use thereofMYRIAD GENETICS INC·Filed 2006·Application pending·0 cites
- 3347US2014024028A1Brca deficiency and methods of useTIMMS KIRSTEN·Filed 2013·Application pending·0 cites
- 3446US2013079423A1Diagnostic methods involving loss of heterozygosityABKEVICH VICTOR·Filed 2011·Application pending·0 cites
- 3543US2013029926A1Compositions and methods for determing cancer susceptibilityMYRIAD GENETICS INC·Filed 2010·Application pending·0 cites
- 3640US2016160294A1Methods and materials for predicting response to niraparibTesaro·Filed 2015·Application pending·0 cites
- 3739US2014113310A9Cancer detection markersSKOLNICK MARK·Filed 2011·Application pending·0 cites
- 3834US2015344966A1Hereditary Cancer DiagnosticsMYRIAD GENETICS INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kirsten Timms files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →